Ranking of Increasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
Globalway 3936 TSE Growth	176	-10 -5.4%	2,088,400	1,180.47	5,076,000	+2,401,700	6.44B	High
OncoTherapy Science 4564 TSE Growth	23	-1 -4.2%	179,113,400	7.64	20,477,300	+2,039,800	8.82B	Mid
BrightPath Biotherapeutics 4594 TSE Growth	59	+4 +7.27%	8,884,400	14.26	20,760,300	+1,414,900	8.19B	Slightly High
MEDINET 2370 TSE Growth	28	0 ー%	240,900	0.00	13,161,900	+678,500	7.77B	Mid
Modalis Therapeutics 4883 TSE Growth	66	-14 -18%	14,371,300	0.00	10,974,900	+657,900	6.1B	Mid
VALUENEX Japan 4422 TSE Growth	1,014	-42 -4.0%	598,700	0.00	579,000	+280,300	8.84B	Slightly High
Asterisk 6522 TSE Growth	1,182	+41 +3.59%	982,300	30.13	1,099,700	+197,300	9.5B	High
D.Western Therapeutics Institute 4576 TSE Growth	91	+1 +1.11%	65,100	0.00	5,750,800	+193,200	5.19B	Slightly High
VELTRA 7048 TSE Growth	162	+2 +1.25%	75,600	2.31	1,136,500	+154,800	5.93B	Mid
Chiome Bioscience 4583 TSE Growth	101	+1 +1.00%	767,600	0.00	6,382,500	+148,600	7.34B	Mid
SymBio Pharma 4582 TSE Growth	90	-2 -2.2%	743,600	0.00	6,171,800	+137,700	6.5B	Slightly High
cotta 3359 TSE Growth	508	-2 -0.4%	11,100	52.15	599,700	+112,000	5.7B	Mid
Aiming 3911 TSE Growth	177	+3 +1.72%	349,700	0.00	4,005,300	+101,500	8.27B	Mid
Softfront Holdings 2321 TSE Growth	177	-6 -3.3%	208,700	0.00	2,055,400	+90,300	9.2B	Slightly High
Photosynth 4379 TSE Growth	458	-1 -0.2%	61,900	0.00	645,200	+76,500	7.17B	Mid
NAKAMURA CHOUKOU 6166 TSE Growth	735	+15 +2.08%	142,300	0.00	1,042,900	+73,800	8.1B	High
Blue innovation 5597 TSE Growth	1,912	+140 +7.90%	676,200	3,115.00	311,500	+61,000	7.71B	High
Noile-Immune Biotech 4893 TSE Growth	152	0 ー%	131,700	0.97	1,660,800	+58,000	6.58B	Mid
Accrete 4395 TSE Growth	1,147	-13 -1.1%	76,200	0.00	914,100	+42,700	8.92B	Slightly High
Hutzper 478A TSE Growth	867	+17 +2.00%	190,200	0.00	846,200	+39,400	8.81B	Slightly High

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels